Ventyx Biosciences Inc [VTYX] stock is trading at $2.34, up 2.18%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VTYX shares have gain 6.85% over the last week, with a monthly amount glided 21.88%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Ventyx Biosciences Inc [NASDAQ: VTYX] stock has seen the most recent analyst activity on March 12, 2024, when Wells Fargo upgraded its rating to a Overweight and also boosted its price target to $16 from $7. Previously, Oppenheimer upgraded its rating to Outperform on March 12, 2024, and kept the price target unchanged to $12. On November 07, 2023, downgrade downgraded it’s rating to Equal Weight and revised its price target to $8 on the stock. Stifel downgraded its rating to a Hold but stick to its price target of $6 on November 07, 2023. Oppenheimer downgraded its rating to a Perform. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 07, 2023, and downed its price target to $6. In a note dated November 07, 2023, H.C. Wainwright downgraded an Neutral rating on this stock.
Ventyx Biosciences Inc [VTYX] stock has fluctuated between $1.79 and $38.20 over the past year. Currently, Wall Street analysts expect the stock to reach $33.86 within the next 12 months. Ventyx Biosciences Inc [NASDAQ: VTYX] shares were valued at $2.34 at the most recent close of the market. An investor can expect a potential return of 1347.01% based on the average VTYX price forecast.
Analyzing the VTYX fundamentals
Gross Profit Margin for this corporation currently stands at -0.29% with Operating Profit Margin at -170.61%, Pretax Profit Margin comes in at -159.2%, and Net Profit Margin reading is -159.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.61 and Total Capital is -0.63. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.26 points at the first support level, and at 2.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.38, and for the 2nd resistance point, it is at 2.43.
Ratios To Look Out For
For context, Ventyx Biosciences Inc’s Current Ratio is 14.19. In addition, the Quick Ratio stands at 14.19 and the Cash Ratio stands at 2.26.
Transactions by insiders
Recent insider trading involved Krueger Christopher W, CHIEF BUSINESS OFFICER, that happened on Apr 02 ’24 when 1651.0 shares were sold. CHIEF SCIENTIFIC OFFICER, Nuss John completed a deal on Apr 02 ’24 to sell 1651.0 shares. Meanwhile, CEO AND PRESIDENT Mohan Raju sold 4312.0 shares on Apr 02 ’24.
